Presentation is loading. Please wait.

Presentation is loading. Please wait.

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants  C.A. Solid,

Similar presentations


Presentation on theme: "Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants  C.A. Solid,"— Presentation transcript:

1 Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants  C.A. Solid, R.N. Foley, J.S. Gill, D.T. Gilbertson, A.J. Collins  Kidney International  Volume 71, Issue 5, Pages (March 2007) DOI: /sj.ki Copyright © 2007 International Society of Nephrology Terms and Conditions

2 Figure 1 Mean hemoglobin levels, dialysis months 1–6. P<0.001 for each month for the comparison of patients with and without failed transplants. Hb, hemoglobin, in g/dl. Kidney International  , DOI: ( /sj.ki ) Copyright © 2007 International Society of Nephrology Terms and Conditions

3 Figure 2 Epoetin doses, dialysis months 1–6. P<0.001 for each month for the comparison of patients with and without failed transplants. Kidney International  , DOI: ( /sj.ki ) Copyright © 2007 International Society of Nephrology Terms and Conditions


Download ppt "Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants  C.A. Solid,"

Similar presentations


Ads by Google